开发和保护新型纳米粒子疫苗的有效性 感染性支气管炎病毒
Ting Xiong1,2, Yanfen Lyu1,2,3,4,5, Hongmei Li2
1College of Veterinary Medicine, South China Agricultural University, Guangzhou 510640, China.
Vaccines
|August 28, 2025
概括
一种新型纳米颗粒疫苗有效地保护免受传染性支气管炎病毒 (IBV) GI-19 的感染. nAP205-S1疫苗诱导了优异的免疫反应和100%的保护,对家禽的健康有希望.
科学领域:
- 兽医病毒学
- 免疫学
- 疫苗中的纳米技术
背景情况:
- 传染性支气管炎病毒 (IBV) 是一种重要的马冠状病毒,对全球家禽产业构成重大威胁.
- 虽然GI-19血统占主导地位,但缺乏有效的商业疫苗.
- 目前的局限性需要开发针对IBV的新型疫苗策略.
研究的目的:
- 开发和评估一种基于纳米粒子的新型疫苗,以对抗IBV的GI-19血统.
- 将纳米粒子疫苗 (nAP205-S1) 与子单位疫苗 (S1-SpyTag) 的免疫性和保护性效果进行比较.
- 评估幽默和细胞免疫反应,以及对病毒挑战的保护.
主要方法:
- 使用CHO和大肠杆菌系统表达S1-SpyTag和AP205-SpyCatcher蛋白质.
- 纯化蛋白质自组合成AP205-S1纳米粒子 (nAP205-S1).
- 用于SPF免疫的油辅助疫苗中的nAP205-S1和S1-SpyTag的配方.
主要成果:
- 在中,nAP205- S1纳米粒子疫苗诱导了强大的IBV特异性幽默和细胞免疫反应.
- 由nAP205-S1引起的免疫反应明显强于S1-SpyTag疫苗引起的免疫反应,特别是细胞免疫.
- 用nAP205- S1接种疫苗导致100%的群体保护,并有效减少病毒分泌.
结论:
- 开发的AP205-S1纳米粒子疫苗显示出对抗GI-19IBV的显著潜力.
- 这种新型纳米粒子疫苗策略为培养家禽广泛的保护性免疫提供了有希望的方法.
- 进一步开发可能会导致针对经济重要IBV血统的有效商业疫苗.
更多相关视频
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.7K
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.9K
相关概念视频
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
01:29Immune Response Against Viral Pathogens
2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
01:23Vaccine Production
144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144